Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-09-28 Sale |
2022-09-30 4:23 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
100,000 | $41.23 | $4,122,670 | 1,324,700 (Indirect) |
View |
| 2022-09-28 Sale |
2022-09-30 4:15 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
32,593 | $41.05 | $1,337,943 | 33,994,660 (Indirect) |
View |
| 2022-09-22 Sale |
2022-09-26 4:30 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
211,380 | $41.17 | $8,702,113 | 34,027,253 (Indirect) |
View |
| 2022-09-20 Sale |
2022-09-22 4:31 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
523,842 | $41.07 | $21,516,554 | 11,848,633 (Indirect) |
View |
| 2022-09-20 Sale |
2022-09-22 4:30 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
267,815 | $41.02 | $10,985,798 | 21,426,170 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 4:30 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. - MGG Strategic MGG Strategic SICAF SIF S.A. Director 10% Owner |
387,171 | $41.59 | $16,101,817 | 34,762,475 (Indirect) |
View |
| 2022-09-16 Sale |
2022-09-20 4:30 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
387,171 | $41.59 | $16,101,934 | 21,693,985 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-16 5:09 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano MGG Strategic SICAF SIF S.A. MGG Strategic SICAF SIF S.A. - MGG Strategic Director 10% Owner |
345,014 | $42.38 | $14,622,925 | 35,149,646 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-16 5:05 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. GG 1978 SICAF SIF S.A. - GG Strategic 10% Owner |
345,014 | $42.38 | $14,623,052 | 22,081,156 (Indirect) |
View |
| 2022-09-14 Sale |
2022-09-15 7:56 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
100,000 | $42.3 | $4,230,387 | 376,899 (Indirect Direct) |
View |
| 2022-09-07 Sale |
2022-09-09 4:18 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
499,500 | $42.7 | $21,327,337 | 35,494,660 (Indirect) |
View |
| 2022-09-07 Sale |
2022-09-09 4:17 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
498,006 | $42.7 | $21,262,534 | 22,426,170 (Indirect) |
View |
| 2022-08-25 Sale |
2022-08-29 5:41 pm |
Royalty Pharma plc | RPRX | GG 1978 SICAF SIF S.A. - GG Strategic GG 1978 SICAF SIF S.A. 10% Owner |
1,994 | $44 | $87,736 | 22,924,176 (Indirect) |
View |
| 2022-08-25 Sale |
2022-08-29 5:40 pm |
Royalty Pharma plc | RPRX | Giuliani Mario Germano Skyeline Management Ltd Avara Management Ltd Director 10% Owner |
500 | $44 | $22,000 | 35,994,160 (Indirect) |
View |
| 2022-08-09 Sale |
2022-08-11 5:07 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
45,000 | $43.73 | $1,967,823 | 476,899 (Indirect Direct) |
View |
| 2022-08-09 Sale |
2022-08-11 5:02 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
20,854 | $43.92 | $915,909 | 1,357,945 (Indirect Direct) |
View |
| 2022-08-01 Sale |
2022-08-03 7:12 pm |
Royalty Pharma plc | RPRX | Coyne Terrance P. EVP & CFO |
30,000 | $43.19 | $1,295,727 | 1,020,390 (Indirect Direct) |
View |
| 2022-07-28 Sale |
2022-08-01 5:01 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
4,046 | $43.97 | $177,893 | 1,378,799 (Indirect Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 6:20 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
75,100 | $43.25 | $3,248,199 | 1,002,845 (Indirect Direct) |
View |
| 2022-07-25 Sale |
2022-07-27 6:17 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,334 | $43.18 | $1,007,446 | 19,020 (Indirect Direct) |
View |
| 2022-06-29 Sale |
2022-06-29 6:02 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
30,000 | $42.17 | $1,265,238 | 521,899 (Indirect Direct) |
View |
| 2022-06-24 Sale |
2022-06-24 5:19 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,333 | $43.19 | $1,007,694 | 42,354 (Indirect Direct) |
View |
| 2022-06-08 Sale |
2022-06-10 5:13 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
100,000 | $41.56 | $4,155,900 | 945,830 (Indirect) |
View |
| 2022-05-27 Sale |
2022-05-31 5:23 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
75,000 | $41.08 | $3,081,008 | 1,045,830 (Indirect) |
View |
| 2022-05-26 Sale |
2022-05-31 5:19 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
100,000 | $40.29 | $4,029,091 | 1,446,831 (Indirect Direct) |
View |
| 2022-05-23 Sale |
2022-05-25 5:10 pm |
Royalty Pharma plc | RPRX | Lloyd George W. EVP, Investments & GC |
100,000 | $40.27 | $4,026,770 | 1,546,831 (Indirect Direct) |
View |
| 2022-05-19 Sale |
2022-05-23 4:57 pm |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
75,000 | $40.44 | $3,033,128 | 1,120,830 (Indirect) |
View |
| 2022-05-19 Sale |
2022-05-23 4:55 pm |
Royalty Pharma plc | RPRX | RIGGS RORY B Director |
150,000 | $39.42 | $5,913,306 | 551,899 (Indirect Direct) |
View |
| 2022-05-16 Sale |
2022-05-16 7:14 pm |
Royalty Pharma plc | RPRX | Urist Marshall EVP, Research & Investments |
23,333 | $39.85 | $929,836 | 65,687 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-12 Gift |
2022-09-30 4:23 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Reddoch James F. EVP & Chief Scientific Officer |
2,400 | $0 | 1,324,700 (Indirect) |
View |
| 2022-07-08 Option Award |
2022-07-11 7:02 pm |
N/A N/A |
Royalty Pharma plc | RPRX | HODGSON DAVID C Director |
2,346 | $0 | 8,674 (Direct) |
View |
| 2022-06-30 Option Award |
2022-06-30 06:55 am |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
903 | $41.52 | 31,925 (Direct) |
View |
| 2022-06-30 Option Award |
2022-06-30 06:51 am |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
903 | $41.52 | 84,331 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:59 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Norden Gregory Director |
6,328 | $0 | 56,698 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:59 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Engelbert Catherine M. Director |
6,328 | $0 | 25,464 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:57 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Bassler Bonnie L Director |
6,328 | $0 | 31,022 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:57 pm |
N/A N/A |
Royalty Pharma plc | RPRX | LOVE TED W Director |
6,328 | $0 | 29,194 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:55 pm |
N/A N/A |
Royalty Pharma plc | RPRX | DESOUZA ERROL B Director |
6,328 | $0 | 56,698 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:53 pm |
N/A N/A |
Royalty Pharma plc | RPRX | HODGSON DAVID C Director |
6,328 | $0 | 6,328 (Direct) |
View |
| 2022-06-24 Option Award |
2022-06-24 4:49 pm |
N/A N/A |
Royalty Pharma plc | RPRX | Fernandez Henry A Director |
6,328 | $0 | 83,428 (Direct) |
View |